Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
Gaziantep, Turkey
University hospital in Gaziantep
Osmangazi, Gaziantep Üniversitesi Şahinbey Araştırma ve Uygulama Hastanesi, Üniversite Blv., 27310 Şehitkamil/Gaziantep
About Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Eli Lilly and Company
4
Hoffmann-La Roche
1
Clinical Trials at Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
During the past decade, Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2019-07-23
2023-12-06
Active, not recruiting
1,100
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis
2021-03-19
2023-02-10
Completed
665
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
2021-08-25
2022-07-25
Terminated
1,411
MagnetisMM-5: Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
2021-10-04
2025-12-29
Recruiting
589
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
According to Clinical.Site data, the most researched conditions in "Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi" are
"COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "Breast Neoplasms" (1 trials), "Crohn's Disease" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi" in a lesser frequency.
Clinical Trials Intervention Types at Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
Most popular intervention types in "Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi" are "Drug" (10 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials), "Tirzepatide" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
The vast majority of trials in "Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi" are
11 trials for "All" genders.
Clinical Trials Status at Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi
Currently, there are NaN active trials in "Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".